Model
Edge
Oyster Point Pharma Inc.
0001720725
Filing Type
8-K/A
Filing Date
1/12/2023
Updated
1/13/23, 10:06 AM
Filing
8-K/A
Earnings Release
Exhibits
8-K/A
End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws